Longeviti CEO Talks Neurosurgical Implants and COVID-19

Longeviti Neuro Solutions co-founder and CEO, Jesse Christopher stops by Let’s Talk Medtech to discuss the firm; its products; and being at the helm of a company during a pandemic.

Omar Ford

February 12, 2021

1 Min Read
IMG_Feb122021at15051PM.jpg

Longeviti Neuro Solutions has been tasked with advancing neurosurgery through the development of low-profile intracranial implants that address the functional and reconstructive needs of patients with neurological conditions. And the company has been busy lately.

Late last month, the Baltimore, MD-based firm received clearance from FDA of the ClearFit implant for use in ultrasound in post-operative imaging. And last week the company announced results of a study demonstrating that the InvisiShunt implant shows promising outcomes with a low complication rate for patients. Results were published in The Journal of Craniofacial Surgery.

Longeviti’s cofounder and CEO Jesse Christopher stopped by Let’s Talk Medtech to discuss the firm; its products; and being at the helm of a company during a pandemic.  

 

 

About the Author

Omar Ford

Omar Ford is a veteran reporter in the field of medical technology and healthcare journalism. As Editor-in-Chief of MD+DI (Medical Device and Diagnostics Industry), a leading publication in the industry, Ford has established himself as an authoritative voice and a trusted source of information.

Ford, who has a bachelor's degree in print journalism from the University of South Carolina, has dedicated his career to reporting on the latest advancements and trends in the medical device and diagnostic sector.

During his tenure at MD+DI, Ford has covered a wide range of topics, including emerging medical technologies, regulatory developments, market trends, and the rise of artificial intelligence. He has interviewed influential leaders and key opinion leaders in the field, providing readers with valuable perspectives and expert analysis.

 

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like